- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ISR IMMUNE SYSTEM REGULATION Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTELLIA THERAPEUTICS | 10,700 | -1,47 % | Intellia Therapeutics, Inc.: Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates | Presented positive Phase 3 HAELO topline clinical data for lonvo-z in HAE; initiated rolling BLA submission; anticipate U.S. launch in first half of 2027Recently resumed patient screening in MAGNITUDE... ► Artikel lesen | |
| PACIFIC BIOSCIENCES OF CALIFORNIA | 1,090 | +0,18 % | Druck auf Pacific Biosciences nimmt zu: Warum die Geduld der Anleger auf eine harte Probe gestellt wird | Pacific Biosciences gerät zunehmend unter Druck: Die Aktie steht nach einer "significant downward revision of revenue guidance" und dem erzwungenen Aktienrückzug eines Großaktionärs im Fokus. Für Investoren... ► Artikel lesen | |
| ATAIBECKLEY | 3,700 | 0,00 % | RE-RATING VORAUS? 15 MIO. RAISE, NASDAQ & TRUMPS ORDER - UND KEINER SCHAUT HIN? | ||
| BIOMERIEUX | 71,65 | -0,62 % | BioMerieux Q1 Sales Down 3.9% On Organic Basis; Revises 2026 Guidance | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - BioMerieux (EYWN.MU, BIM.PA) reported first quarter consolidated sales of 984 million euros, down 10.4% as reported from last year. On an organic basis,... ► Artikel lesen | |
| BIO GREEN MED SOLUTION | 0,970 | +0,52 % | Bio Green Med Solution, Inc. - 8-K, Current Report | ||
| GENUS | 28,400 | -0,70 % | Dividendenbekanntmachungen (05.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERICAN ASSETS TRUST INC US0240131047 0,34 USD 0,2922 EUR ARMSTRONG WORLD INDUSTRIES INC US04247X1028 0,339 USD 0,2914 EUR ASSOCIATED... ► Artikel lesen | |
| ANAPTYSBIO | 50,32 | +1,37 % | ANAPTYSBIO, INC - 8-K, Current Report | ||
| XTL BIOPHARMACEUTICALS | 1,850 | -0,54 % | XTL Biopharmaceuticals Ltd.: XTL Announces Receipt of Staff Delist Determination from Nasdaq | RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a letter (the "Letter")... ► Artikel lesen | |
| MEIRAGTX | 7,850 | -4,85 % | MeiraGTx Reports First Quarter 2026 Financial and Operational Results | Received FDA Breakthrough Therapy Designation for AAV2-hAQP1Reported positive three-year data from the Phase 1 AQUAx study of AAV2-hAQP1 for the treatment of grade 2/3 late radiation-induced xerostomiaEntered... ► Artikel lesen | |
| AKESO | 12,380 | +1,85 % | HSCEI Adds HANSOH PHARMA and AKESO, Removes SUNNY OPTICAL and HAIER SMARTHOME in Quarterly Review | ||
| ABIONYX PHARMA | 2,980 | -12,22 % | ABIONYX Pharma Launches Fully Secured Capital Increase with Preferential Subscription Rights and Structured Debt Financing for an Aggregate Amount of up to c. EUR 33 M | Size of the Fully Guaranteed Capital Increase with subscription rights: EUR 32.7m Subscription ratio: 1 new share for every 5 existing shares Subscription price: 2.65 euro per new... ► Artikel lesen | |
| MAAT PHARMA | 2,915 | -2,02 % | MaaT Pharma Provides Business Update and Reports Financial Results for the First Quarter 2026 | MaaT013 (Xervyteg):
In May 2026, the Company was informed of a "negative trend" opinion on its Marketing Authorization Application from the Committee for Medicinal Products for Human Use... ► Artikel lesen | |
| ISOFOL MEDICAL | 0,050 | -2,54 % | Isofol Medical AB: Bulletin from annual general meeting in Isofol Medical AB (publ) held on 19 May, 2026 | GOTHENBURG, Sweden, May 19, 2026 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL) (the "Company") held its annual general meeting (the "AGM") today. The following resolutions, in principle, were... ► Artikel lesen | |
| DIAGONAL BIO | 0,004 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.12.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 19.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.12.2025ISIN NameCA74349R1055 PROPHECY... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 21,110 | 0,00 % | Arcutis Biotherapeutics, Inc.: Arcutis' ZORYVE (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines | Strong recommendation with high certainty of clinical evidence underscores proven efficacy, safety, and tolerability of ZORYVE cream as a steroid-free topical phosphodiesterase type 4 (PDE4) inhibitorAtopic... ► Artikel lesen |
ISR IMMUNE SYSTEM REGULATION HOLDING AB gehört der Branche Biotechnologie an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ISR IMMUNE SYSTEM REGULATION HOLDING AB finden Sie auf Wallstreet Online.